Therefore, patients with different disease outcomes can be identified at early stages of infection making hepatitis C an ideal model to study the process of differentiation from early exhaustion-committed to late fully exhausted CD8+ T cells in humans. This evidence concerns the gene CD8A and hepatitis C virus infection.